168 results
8-K
PIRS
Pieris Pharmaceuticals Inc
27 Mar 24
Pieris Pharmaceuticals Announces Strategy to Maximize Partnered Milestone and Royalty Potential
8:00am
December 31, 2023 and is subject to completion of the Company’s financial closing procedures and may change. The Company’s independent registered public
S-8
EX-23.1
nm28x02rtyt9902xtmui
10 Aug 23
Registration of securities for employees
5:04pm
8-K
c3htej 2cf
18 Jul 23
Pieris Pharmaceuticals Provides Strategic Update and Announces Restructuring
9:15am
8-K
sg9aveii3zxu
26 Jun 23
Departure of Directors or Certain Officers
5:25pm
8-K
v7g7a3n mp7
21 Jun 23
Results of Operations and Financial Condition
7:00am
8-K
EX-99.1
nd8imvdbr
21 Jun 23
Results of Operations and Financial Condition
7:00am
424B5
anb00h 53yzck27i4he
4 Nov 22
Prospectus supplement for primary offering
5:10pm
8-K
EX-5.1
nfdyrysom
4 Nov 22
Entry into a Material Definitive Agreement
4:30pm
8-K
EX-99.1
hmjq 40ih
13 Sep 22
PIERIS PHARMACEUTICALS SUPERIOR MEDICINES THROUGH EFFICIENT BIOLOGY CORPORATE PRESENTATION September 2022
8:23am